Media Coverage

[Food Navigator] ‘A Christmas wish come true’: CBD industry celebrates as EC resumes Novel Food applications

  • by

More good news for the CBD industry. The European Commission has abandoned its plans to classify non-synthetic CBD a narcotic and resumed Novel Food applications for edible CBD products.

The move came after the European Court of Justice ruled that CBD is not a narcotic drug as it “does not appear to have any psychotropic effect or any harmful effect on human health”.​

[Confectionary News] Are functional jellies and candy a good fit for the confectionery sector?

ConfectioneryNews looks at some of the benefits, and also the issues, of using dietary and medicinal ingredients in sweets. The use of confectionery products to carry over-the-counter (OTC) medications or dietary supplements is increasing as consumers realise that hard candy, jellies or fruit products are one of the quickest ways of getting nutrients into the body. The demand for functional jellies continues to grow with herbal extracts, cannabinoids and vitamins proving a good fit with the mainstream candy sector.

[Health Europa] EU court rules CBD is ‘not a narcotic’

  • by

The ruling is a boost to the CBD sector in Europe after the EU decision to potentially classify CBD as a narcotic. The court stated that: ‘A Member State may not prohibit the marketing of cannabidiol (CBD) lawfully produced in another Member State when it is extracted from the Cannabis sativa plant in its entirety and not solely from its fibre and seeds.’ And that: ‘the provisions on the free movement of goods within the European Union (Articles 34 and 36 TFEU) are applicable, since the CBD at issue in the main proceedings cannot be regarded as a ‘narcotic drug’.’

[Food Navigator] ‘A breakthrough for the market’: Europe’s highest court rules CBD is not a narcotic

  • by

Europe’s CBD market is optimistic a ruling from the EU’s highest court not to classify the ingredient a narcotic – going against the European Commission’s shock preliminary view in July – will pave the way for Novel Food applications for CBD products to re-start.

The Court of Justice of the European Union ruled CBD is not a narcotic drug as it “does not appear to have any psychotropic effect or any harmful effect on human health”.​

[Analytical Cannabis] Inside the ACI’s CBD Safety Trial

  • by

The UK’s CBD industry is about to hit a crossroads. In just under five months’ time, every CBD company in the country will fall on one side of a new divide: those that have submitted a novel foods application with the country’s Food Standards Agency (FSA), and those that have not. To learn more about these time constraints and just what a CBD toxicology is, Analytical Cannabis spoke with Dr Paul Duffy, the ACI’s lead toxicologist.